135 related articles for article (PubMed ID: 33884582)
1. Isogenic human pluripotent stem cell disease models reveal ABRA deficiency underlies cTnT mutation-induced familial dilated cardiomyopathy.
Li B; Zhan Y; Liang Q; Xu C; Zhou X; Cai H; Zheng Y; Guo Y; Wang L; Qiu W; Cui B; Lu C; Qian R; Zhou P; Chen H; Liu Y; Chen S; Li X; Sun N
Protein Cell; 2022 Jan; 13(1):65-71. PubMed ID: 33884582
[No Abstract] [Full Text] [Related]
2. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
Wu H; Lee J; Vincent LG; Wang Q; Gu M; Lan F; Churko JM; Sallam KI; Matsa E; Sharma A; Gold JD; Engler AJ; Xiang YK; Bers DM; Wu JC
Cell Stem Cell; 2015 Jul; 17(1):89-100. PubMed ID: 26095046
[TBL] [Abstract][Full Text] [Related]
3. Human induced pluripotent stem cell line YCMi007-A generated from a dilated cardiomyopathy patient with a heterozygous dominant c.613C > T (p. Arg205Trp) variant of the TNNT2 gene.
Jeon SB; Kim H; Chun KH; Oh J; Kwon C; Choi HK; Kim S; Kim HP; Kim IC; Yoo JY; Park SW; Kang SM; Lee SH
Stem Cell Res; 2023 Mar; 67():103048. PubMed ID: 36801602
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
[TBL] [Abstract][Full Text] [Related]
5. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
Parvatiyar MS; Pinto JR
Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
[TBL] [Abstract][Full Text] [Related]
7. GSK-3β heterozygous knockout is cardioprotective in a knockin mouse model of familial dilated cardiomyopathy.
Mohamed RM; Morimoto S; Ibrahim IA; Zhan DY; Du CK; Arioka M; Yoshihara T; Takahashi-Yanaga F; Sasaguri T
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1808-15. PubMed ID: 27106044
[TBL] [Abstract][Full Text] [Related]
8. A perspective on Notch signalling in progression and arrhythmogenesis in familial hypertrophic and dilated cardiomyopathies.
Langa P; Shafaattalab S; Goldspink PH; Wolska BM; Fernandes AA; Tibbits GF; Solaro RJ
Philos Trans R Soc Lond B Biol Sci; 2023 Jun; 378(1879):20220176. PubMed ID: 37122209
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of a unique troponin c mutation, GLY159ASP, that causes familial dilated cardiomyopathy, studied in explanted heart muscle.
Dyer EC; Jacques AM; Hoskins AC; Ward DG; Gallon CE; Messer AE; Kaski JP; Burch M; Kentish JC; Marston SB
Circ Heart Fail; 2009 Sep; 2(5):456-64. PubMed ID: 19808376
[TBL] [Abstract][Full Text] [Related]
10. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
[TBL] [Abstract][Full Text] [Related]
11. Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin Overlap.
McConnell M; Tal Grinspan L; Williams MR; Lynn ML; Schwartz BA; Fass OZ; Schwartz SD; Tardiff JC
Biochemistry; 2017 Jul; 56(26):3403-3413. PubMed ID: 28603979
[TBL] [Abstract][Full Text] [Related]
12. The functional effect of dilated cardiomyopathy mutation (R144W) in mouse cardiac troponin T is differently affected by α- and β-myosin heavy chain isoforms.
Gollapudi SK; Tardiff JC; Chandra M
Am J Physiol Heart Circ Physiol; 2015 Apr; 308(8):H884-93. PubMed ID: 25681424
[TBL] [Abstract][Full Text] [Related]
13. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
[TBL] [Abstract][Full Text] [Related]
14. Cardiac-specific deletion of the microtubule-binding protein CENP-F causes dilated cardiomyopathy.
Dees E; Miller PM; Moynihan KL; Pooley RD; Hunt RP; Galindo CL; Rottman JN; Bader DM
Dis Model Mech; 2012 Jul; 5(4):468-80. PubMed ID: 22563055
[TBL] [Abstract][Full Text] [Related]
15. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Burridge PW; Diecke S; Matsa E; Sharma A; Wu H; Wu JC
Methods Mol Biol; 2016; 1353():119-30. PubMed ID: 25690476
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a human induced pluripotent stem cell line from a patient with dilated cardiomyopathy.
Ye L; Ni B; Wu H; Han X; Li H; Liu J; Hu S; Lei W
Stem Cell Res; 2024 Aug; 78():103467. PubMed ID: 38861774
[TBL] [Abstract][Full Text] [Related]
17. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
[TBL] [Abstract][Full Text] [Related]
18. Non-negative blind deconvolution for signal processing in a CRISPR-edited iPSC-cardiomyocyte model of dilated cardiomyopathy.
Xu H; Wali R; Cheruiyot C; Bodenschatz J; Hasenfuss G; Janshoff A; Habeck M; Ebert A
FEBS Lett; 2021 Oct; 595(20):2544-2557. PubMed ID: 34482543
[TBL] [Abstract][Full Text] [Related]
19. A troponin T variant linked with pediatric dilated cardiomyopathy reduces the coupling of thin filament activation to myosin and calcium binding.
Barrick SK; Greenberg L; Greenberg MJ
Mol Biol Cell; 2021 Aug; 32(18):1677-1689. PubMed ID: 34161147
[TBL] [Abstract][Full Text] [Related]
20. Functional Annotation of TNNT2 Variants of Uncertain Significance With Genome-Edited Cardiomyocytes.
Lv W; Qiao L; Petrenko N; Li W; Owens AT; McDermott-Roe C; Musunuru K
Circulation; 2018 Dec; 138(24):2852-2854. PubMed ID: 30565988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
